相关实验视频
Updated: Sep 13, 2025
05:37
An R-Based Landscape Validation of a Competing Risk Model
Published on: September 16, 2022
2.2K
重症患者死亡率的新预后得分. 开发和验证的发展和验证
M P Gracia Arnillas1, F Alvarez Lerma1, X Nuvials Casals2
1Critical Care Department, Hospital Universitari del Mar, Passeig Marítim 25-29, 08003 Barcelona, Spain.
Journal of critical care
|August 2, 2025
概括
一个新的预后模型通过结合APACHE II之外的9个额外的风险因素,准确地预测了重症监护室 (ICU) 的死亡率. 这种新型模型增强了重症患者的风险分层,改善了患者的治疗结果.
科学领域:
- 关键护理医学 关键护理医学
- 预测模型的预测建模
- 医疗信息学 医疗信息学
背景情况:
- 预测重症患者的死亡率对于有效的资源配置和治疗策略至关重要.
- 像APACHE II这样的现有模型在整个ICU停留期间捕捉动态风险因素方面存在局限性.
研究的目的:
- 开发和验证一种新的预后模型 (NMP) 来预测ICU死亡率.
- 通过纳入动态风险因素来提高 APACHE II 评分的预测准确性.
主要方法:
- 在7年间对167家西班牙医院 (193个ICU) 的多中心,前性数据进行了后期分析.
- 多变量逻辑回归被用于在估计组中开发模型,并在单独的队列中验证.
- 国家医疗计划包括APACHE II和在整个ICU逗留期间评估的9个额外因素.
主要成果:
- 该研究分析了137,666名患者,其中估计组的91,777名患者和验证组的45,889名患者.
- 与单独使用APACHE II (AUROC = 0.826) 相比,NMP显示出更高的区分能力 (AUROC = 0.872).
- 国家医疗计划提高了52%的重新分类,更准确地识别了幸存者和非幸存者.
结论:
- 开发了一种经过验证的新型预后模型 (NMP),它与APACHE II.一起结合了9个额外的风险因素.
- 国家医疗计划为重症患者提供了增强的风险分层,有助于临床决策.
- 该模型提供了一个更全面的评估死亡风险在整个ICU停留期间.
相关概念视频
01:24Kaplan-Meier Approach
266
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
266
01:20Comparing the Survival Analysis of Two or More Groups
287
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
287
01:21Cancer Survival Analysis
455
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
455